BioVie (BIVI) 10-Q2022 Q2 Quarterly report

Filed: 10 Feb 23, 5:16pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. junior Avg

New words: absence, abuse, accuracy, AD, adding, adhere, agent, ALS, alternative, Amyotrophic, apparent, cautioned, Chemistry, comply, compound, compromised, coordinating, CRO, dementia, demonstrate, devote, enhancement, entitled, facilitate, false, Fast, formulation, fraud, frontotemporal, good, government, healthcare, heavily, important, inaccurate, incomplete, interaction, investigator, kinase, lag, learn, levodopa, lobar, monitor, monitoring, nonclinical, objective, oxidative, partly, permeable, preclinical, privacy, promotoric, quality, released, reliance, relieve, responsible, secondary, sensitizing, site, speak, staffing, Switching, Track, training, transition, undue

Removed: alcoholism, Amendment, anticipating, arising, arrangement, ASU, begin, cascade, debenture, decrease, Diary, efficacy, eligibility, Exploratory, exploring, finance, Forty, frequent, initial, instrument, largely, line, medication, mortality, Motor, multiple, myeloma, NASH, overcome, participate, prostate, range, Rating, retained, Scale, Society, standard, suffer, Symptom, target, therapy, top, transferred, unconsolidated, underway, Unified, unmet, variable, viability, website

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BIVI similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S. C. SECTION 1350 AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of BioVie Inc. (the “Company”) on Form 10-Q for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Cuong V Do, Chief Executive Officer of the Company certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002, that, to my knowledge:

(1)	The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 10, 2023

								/s/ Cuong V Do
								Cuong V Do Chief Executive Officer (Principal Executive Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.